drugset / Trial / NCT04143451
Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients
RandomizedCrossoverDouble-blindPrevention
Summary
To compare the safety and clinical efficacy (death, overall hospitalization, hospitalization for influenza or pneumonia) of ID QIV delivered via an intradermal device with imiquimod cream pretreatment with conventional intramuscular (IM) standard dose QIV and IM high-dose TIV
Timeline
- Start
- 2019-10-23
- Primary completion
- 2022-09-30
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Imiquimod | Other / unclassified | 5 % | Topical |
| Comparator | Imiquimod | Other / unclassified | 250 mg | Topical |
| Comparator | Influenza Virus Vaccine | Vaccine | 60 ug | Intramuscular |
| Comparator | NITRAMINE | Vaccine | 15 ug | Intramuscular |